|
MARK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.744600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.879350E-01 |
| Normal-vs-Stage2 |
5.422600E-01 |
| Normal-vs-Stage3 |
5.940400E-01 |
| Normal-vs-Stage4 |
1.918630E-01 |
| Stage1-vs-Stage2 |
7.977400E-01 |
| Stage1-vs-Stage3 |
7.348000E-01 |
| Stage1-vs-Stage4 |
4.428600E-01 |
| Stage2-vs-Stage3 |
9.690200E-01 |
| Stage2-vs-Stage4 |
3.412000E-01 |
| Stage3-vs-Stage4 |
3.368000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.477800E-01 |
| Normal-vs-AfricanAmerican |
5.245000E-01 |
| Normal-vs-Asian |
5.905200E-01 |
| Caucasian-vs-AfricanAmerican |
6.971800E-01 |
| Caucasian-vs-Asian |
8.303600E-01 |
| AfricanAmerican-vs-Asian |
6.943600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.230300E-02 |
| Normal-vs-Female |
2.505600E-01 |
| Male-vs-Female |
7.960200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.050400E-01 |
| Normal-vs-Extreme_Weight |
7.224000E-02 |
| Normal-vs-Obese |
9.524600E-01 |
| Normal-vs-Extreme_Obese |
5.949800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.069200E-01 |
| Normal_Weight-vs-Obese |
2.598800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.488600E-01 |
| Extreme_Weight-vs-Obese |
1.177840E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.445200E-01 |
| Obese-vs-Extreme_Obese |
7.259400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.283780E-01 |
| Normal-vs-Age(41-60Yrs) |
9.014400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.274300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.679600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.375000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.399600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.961400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.400200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.471600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.922450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.184600E-01 |
| Normal-VS-Type2 PRCC |
2.175500E-03 |
| Normal-VS-KIRP CIMP |
1.974230E-01 |
| Normal-VS-Unclassified PRCC |
8.772200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.202500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.391160E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.196000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.798000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.206170E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.785000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.489970E-02 |
| Normal-vs-N1 |
7.553400E-01 |
| Normal-vs-N2 |
8.301200E-01 |
| N0-vs-N1 |
1.295630E-01 |
| N0-vs-N2 |
5.401800E-01 |
| N1-vs-N2 |
9.023000E-01 |
|
|
